Business Context and Reporting Period
This Form 8-K is a current report filed by Second Sight Medical Products, Inc. (not Vivani Medical, Inc.) on January 24, 2018. The filing addresses Item 5.02 regarding the departure of directors or officers, election of directors, appointment of officers, and compensatory arrangements.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to specific executive bonus awards approved for the performance year ended December 31, 2017:
- Jonathan Will McGuire (President and CEO): $213,070.28
- Robert J. Greenberg (Chairman of the Board): $147,819.53
- Thomas B. Miller (Chief Financial Officer): $95,301.23
- Edward Randolph (Vice President, Operations): $70,930.80
- David Jacques (Vice President, R&D): $59,732.90
Material Changes
The material change reported is the approval of performance-based bonuses for executive and non-executive staff. These awards were granted based on the achievement of individual milestones and the Company's overall performance for the year ended December 31, 2017.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, market outlook, or discussion of specific risks and contingencies beyond the standard disclosure of the bonus approval process. The text does not provide a clear value for future financial projections.
Investor Verification Checklist
- Verify the registrant name is Second Sight Medical Products, Inc., not Vivani Medical, Inc.
- Confirm the total cash outflow for executive bonuses approved in this filing.
- Review the Company's 2017 Annual Report (10-K) to understand the specific "targeted milestones" that triggered these bonuses.
- Check for any subsequent filings regarding the actual payment dates of these awards.